Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase

Bioorg Med Chem Lett. 2005 Feb 15;15(4):989-94. doi: 10.1016/j.bmcl.2004.12.046.

Abstract

Docking experiments using a number of published crystal structures of HMG-CoA reductase with the potent hypocholesterolemic agent alpha-asarone are described. The results indicate that alpha-asarone binds in the enzyme's active site. The methoxy groups play a key role in the binding and probably also in its biological activity, as shown by extensive SAR studies reported for analogues of alpha-asarone. The docking results will be valuable for the structure-based design of novel hypolipidemic agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allylbenzene Derivatives
  • Anisoles / chemistry*
  • Binding Sites
  • Catalytic Domain
  • Computer Simulation*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Hydroxymethylglutaryl CoA Reductases / chemistry*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / chemistry*
  • Models, Molecular
  • Protein Binding
  • Structure-Activity Relationship

Substances

  • Allylbenzene Derivatives
  • Anisoles
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • asarone
  • Hydroxymethylglutaryl CoA Reductases